Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Mitos, mistis, dan masa depan pengetahuan lokal

CC BYDi banyak tempat di Indonesia, mitos bukan sekadar dongeng pengantar tidur atau kisah seram penuh mistis. Ia lahir dari upaya masyarakat untuk memahami dunia di sekitarnya, mulai dari bagaimana m...

Krisis legitimasi pejabat negara: Terpilih dalam pemilu, tapi gagal jaga kepercayaan rakyat

Pengendara motor melintasi alat kampanye untuk calon anggota legislatif nasional dan daerah jelang Pemilu 2024 di Bintaro, Tangerang Selatan, pada 29 Desember 2023.Gilangpnp/Shutterstock● Masyar...

Belajar dari pasangan Jawa dan Tionghoa: Strategi negosiasi untuk hubungan antar etnis

Pernikahan Antar Etnis antara Jawa dan TionghoaLipik Stock Media/Shuttershock● Pernikahan beda suku tak selalu kental dengan konflik antar etnis.● Pernikahan antar etnis justru menghasilka...